A Prospective, Comparative Study of Quality of Life among Patients with Small Renal Masses Choosing Active Surveillance and Primary Intervention

Journal of Urology

Volumn 196, Issue 5, 2016, Pages 1356-1362

  Patel, Hiten D ^a   Riffon, Mark F ^a   Joice, Gregory A ^a   Johnson, Michael H ^a   Chang, Peter ^b   Wagner, Andrew A ^b   McKiernan, James M ^c   Trock, Bruce J ^a   Allaf, Mohamad E ^a   Pierorazio, Phillip M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

carcinoma; early medical intervention; kidney neoplasms; quality of life; renal cell; watchful waiting

Indexed keywords

ANXIETY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; FEMALE; FOLLOW UP; HUMAN; KIDNEY TUMOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SHORT FORM 12; ADULT; CLINICAL TRIAL; EARLY INTERVENTION; MULTICENTER STUDY; PATHOLOGY; REGISTER; TUMOR VOLUME; WATCHFUL WAITING;

ADULT; EARLY MEDICAL INTERVENTION; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; PROSPECTIVE STUDIES; QUALITY OF LIFE; REGISTRIES; TUMOR BURDEN; WATCHFUL WAITING;

EID: 84992413329     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2016.04.073     Document Type: Article

References (30)

1. 1 Hollingsworth, J.M., Miller, D.C., Daignault, S., et al. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst, 98, 2006, 1331.
2. 2 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Kidney Cancer, 2014, National Comprehensive Cancer Network, Fort Washington, Pennsylvania.
3. 3 Campbell, S.C., Novick, A.C., Belldegrun, A., et al. Guideline for management of the clinical T1 renal mass. J Urol, 182, 2009, 1271.
4. 4 Ljungberg, B., Cowan, N.C., Hanbury, D.C., et al. EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol, 58, 2010, 398.
5. 5 Patel, H.D., Kates, M., Pierorazio, P.M., et al. Balancing cardiovascular (CV) and cancer death among patients with small renal masses: modification by CV risk. BJU Int, 115, 2015, 58.
6. 6 Jewett, M.A., Mattar, K., Basiuk, J., et al. Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol, 60, 2011, 39.
7. 7 Smaldone, M.C., Kutikov, A., Egleston, B.L., et al. Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer, 118, 2012, 997.
8. 8 Patel, H.D., Kates, M., Pierorazio, P.M., et al. Survival after diagnosis of localized T1a kidney cancer: current population-based practice of surgery and nonsurgical management. Urology, 83, 2014, 126.
9. 9 Clark, P.E., Schover, L.R., Uzzo, R.G., et al. Quality of life and psychological adaptation after surgical treatment for localized renal cell carcinoma: impact of the amount of remaining renal tissue. Urology, 57, 2001, 252.
10. 10 Gratzke, C., Seitz, M., Bayrle, F., et al. Quality of life and perioperative outcomes after retroperitoneoscopic radical nephrectomy (RN), open RN and nephron-sparing surgery in patients with renal cell carcinoma. BJU Int, 104, 2009, 470.
11. 11 Poulakis, V., Witzsch, U., de Vries, R., et al. Quality of life after surgery for localized renal cell carcinoma: comparison between radical nephrectomy and nephron-sparing surgery. Urology, 62, 2003, 814.
12. 12 Parker, P.A., Swartz, R., Fellman, B., et al. Comprehensive assessment of quality of life and psychosocial adjustment in patients with renal tumors undergoing open, laparoscopic and nephron sparing surgery. J Urol, 187, 2012, 822.
13. 13 Onishi, T., Nishikawa, K., Hasegawa, Y., et al. Assessment of health-related quality of life after radiofrequency ablation or laparoscopic surgery for small renal cell carcinoma: a prospective study with medical outcomes Study 36-Item Health Survey (SF-36). Jpn J Clin Oncol, 37, 2007, 750.
14. 14 Ficarra, V., Novella, G., Sarti, A., et al. Psycho-social well-being and general health status after surgical treatment for localized renal cell carcinoma. Int Urol Nephrol, 34, 2002, 441.
15. 15 Parker, P.A., Alba, F., Fellman, B., et al. Illness uncertainty and quality of life of patients with small renal tumors undergoing watchful waiting: a 2-year prospective study. Eur Urol, 63, 2013, 1122.
16. 16 Pierorazio, P.M., Hyams, E.S., Mullins, J.K., et al. Active surveillance for small renal masses. Rev Urol, 14, 2012, 13.
17. 17 Donat, S.M., Diaz, M., Bishoff, J.T., et al. Follow-up for clinically localized renal neoplasms: AUA guideline. J Urol, 190, 2013, 407.
18. 18 Johnson, J.A., Pickard, A.S., Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada. Med Care, 38, 2000, 115.
19. 19 Brazier, J.E., Roberts, J., The estimation of a preference-based measure of health from the SF-12. Med Care, 42, 2004, 851.
20. 20 Gandek, B., Ware, J.E., Aaronson, N.K., et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol, 51, 1998, 1171.
21. 21 Patel, H.D., Kates, M., Pierorazio, P.M., et al. Comorbidities and causes of death in the management of localized T1a kidney cancer. Int J Urol, 21, 2014, 1086.
22. 22 Becker, G., Kaufman, S.R., Managing an uncertain illness trajectory in old age: patients’ and physicians’ views of stroke. Med Anthropol Q, 9, 1995, 165.
23. 23 Chawla, S.N., Crispen, P.L., Hanlon, A.L., et al. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol, 175, 2006, 425.
24. 24 Pierorazio, P.M., Johnson, M.H., Ball, M.W., et al. Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry. Eur Urol, 68, 2015, 408.
25. 25 Pierorazio, P.M., Johnson, M.H., Patel, H.D., et al. Management of Renal Masses and Localized Renal Cancer. Effective Health Care Program Comparative Effectiveness Review No. 167. AHRQ Publication No. 16-EHC001-EF. 2016, Agency for Healthcare Research and Quality, Rockville.
26. 26 Vasarainen, H., Lokman, U., Ruutu, M., et al. Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial. BJU Int, 109, 2012, 1614.
27. 27 Wilcox, C.B., Gilbourd, D., Louie-Johnsun, M., Anxiety and health-related quality of life (HRQL) in patients undergoing active surveillance of prostate cancer in an Australian centre. BJU Int, 113(suppl.), 2014, 64.
28. 28 Patel, H.D., Johnson, M.H., Pierorazio, P.M., et al. Diagnostic accuracy and risks of biopsy in the diagnosis of a renal mass suspicious for localized renal cell carcinoma: systematic review of the literature. J Urol, 195, 2016, 1340.
29. 29 Lesage, K., Joniau, S., Fransis, K., et al. Comparison between open partial and radical nephrectomy for renal tumours: perioperative outcome and health-related quality of life. Eur Urol, 51, 2007, 614.
30. 30 MacLennan, S., Imamura, M., Lapitan, M.C., et al. Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer. Eur Urol, 62, 2012, 1097.